Sutib 50mg Sunitinib Price USA | Ernest Impex Indian Exporter

Sutib 50mg Capsule: High-Potency Targeted Therapy for Advanced Oncology

Are you searching for a dependable Sutib 50 mg capsule exporter from India? Ernest Impex, a key division of the Group of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of advanced multi-kinase inhibitors. We maintain a high-authority, regulatory-compliant supply chain serving Washington (USA), London (UK), Bangkok (Thailand), Canberra (Australia), Singapore, and Kingston (Jamaica), ensuring that critical cancer treatments are delivered with pharmaceutical-grade integrity and efficient global logistics.

Detailed Product Overview: What is Sutib 50mg?

Sutib 50mg Capsule is an oral oncology medication containing the active ingredient Sunitinib. It belongs to a class of drugs known as multi-targeted tyrosine kinase inhibitors (TKIs). Manufactured by Zydus Oncosciences, Sutib 50mg is a high-dose formulation designed to interfere with the signaling pathways that cancer cells use to grow, divide, and develop new blood vessels.

For international B2B procurement, Sutib 50mg (supplied as a high-concentration oral capsule) provides a clinically validated solution for treating specific solid tumors that are resistant to standard chemotherapy.

Primary Therapeutic Indications

Sutib 50mg is clinically utilized globally for:

1. Gastrointestinal Stromal Tumor (GIST): For patients whose disease has progressed or who are intolerant to Imatinib.

2. Advanced Renal Cell Carcinoma (mRCC): Used as a primary treatment to slow the progression of metastatic kidney cancer.

3. Pancreatic Neuroendocrine Tumors (pNET): For progressive, well-differentiated tumors in patients with unresectable locally advanced or metastatic disease.

Mechanism of Action: How Sunitinib Inhibits Tumor Growth

Sutib works through a dual-action biological process that targets both the tumor cell and its survival environment:

• Receptor Inhibition: Sunitinib inhibits multiple receptor tyrosine kinases (RTKs), including all receptors for vascular endothelial growth factors (VEGFR-1, -2, -3) and platelet-derived growth factors (PDGFR-α and -β).

• Anti-Angiogenesis: By blocking VEGFR, it prevents the tumor from forming the new blood vessels it needs to grow.

• Cell Proliferation Blockade: It targets the KIT (stem cell factor receptor) and FLT3, interrupting the internal signals that tell cancer cells to multiply.

• Apoptosis Induction: This blockade effectively slows tumor growth and can lead to cancer cell death.

Administration and Clinical Safety

• Dosage Protocol: Usually taken once daily. In GIST and RCC, a common schedule is 4 weeks on treatment followed by 2 weeks off.

• Storage: Store at room temperature (20°C to 25°C). Protect from moisture and keep the container tightly closed.

• Key Monitoring:

• Cardiovascular Safety: Patients should be monitored for hypertension and left ventricular ejection fraction (LVEF).

• Hepatotoxicity: Liver function tests (ALT, AST, Bilirubin) are required periodically.

• Thyroid Function: Screening for hypothyroidism is standard during Sunitinib therapy.

• Dermatologic Effects: Monitoring for hand-foot skin syndrome and skin discoloration is recommended.

Why Source Sutib from Ernest Impex?

• Authentic Indian Exporter: Direct access to genuine Zydus Oncosciences inventory, providing 100% product authenticity and competitive wholesale pricing for international markets.

• Global Distribution Authority: We specialize in the complex documentation and logistics required for shipping oncology medications to Washington, London, Bangkok, Canberra, Singapore, and Kingston.

• Regulatory Compliance: We provide all essential B2B documentation, including GMP compliance, batch-specific COAs, and necessary international export permits.

• Bulk Supply Stability: We specialize in large-scale fulfillment for hospital pharmacies, oncology networks, and regional distributors.